Placeras Pär Ståhl, Karl Lans, Pekka Kääntä och Martin Blomgren pratar öppna upp vinnare, en lyxaktie och en grön vinnaraktie, räntan och vad vi köpt och sålt i veckan. Pekka avslöjar varför han sålt sina svenska innehav och vad han letar efter nu.
Aktierna som nämns finns här: https://www.avanza.se/placera/redaktionellt/2021/04/09/redaktionspodden-har-tar-vi-hem-vinsterna-nu.plc.html

Redaktionspodden: Här tar vi hem vinsterna nu

Placeras Jesper Norberg, Martin Blomgren, Pär Ståhl och Pekka Kääntä går igenom veckans rapportskörd. De diskuterar om SPAC:arna nått toppen, inköpschefsindex, förnyat intresse för ESG-bolagen och Pekka avslöjar vad som ligger bakom ränteuppgången som kom av sig.

Aktier: Apple, Duni, Essity, Hermès, Hugo Boss, Kungsleden, LVHM, Vestas och Volvo

Samtalet spelades in den 23 april 2021

(Beklagar sämre ljudkvalitet)

Redaktionspodden:  Mer börsbränsle efter stark rapportvecka

Analytikerna samlas för att diskutera börsläget och kvartalsrapporter. På agendan står en lång rad bolag med olika storlek och profil. Hur ska man tolka senaste tidens kursfluktuationer? Vilka aktier fungerar oavsett börsklimat? Kan storbanken vara ett bra köp nu? Finns det mer potential i digitala tillväxtstjärnan?

 

Det och mycket mer i senaste avsnittet av Aktiepodden, inspelat den 6 maj 2021.

 

Bolag som nämns i avsnittet:

 

Beijer Alma
Fagerhult
Orkla
SEB
Avanza

Avsnitt 121: Trygga aktier i osäkra tider

སྒྲ་ཨང་། KADZT2060190
མཁས་པ་གཞན། ༼གཞུང་ཆེན།༽ སྤྱིའི་ཨང་། ༣༠༩
འཁྲིད་མཁན། སེར་བྱེས་དགེ་བཤེས་འཇམ་དཔལ་བློ་ཤེས། 
ཁྲིད་ཚན། དོགས་གཅོད། 
ཁྲིད་གཞུང་གི་མཚན་ཆ་ཚང་། ཚད་མ་རྣམ་འགྲེལ་གྱི་ཚིག་ལེའུ་བྱས་པ་ལེའུ་དང་པོའི་རྣམ་བཤད་ཐར་ལམ་ཕྱིན་ཅི་མ་ལོག་པར་གསལ་བར་བྱེད་པ་ཞེས་བྱ་བ། 
མཛད་པ་པོ། རྒྱལ་ཚབ་དར་མ་རིན་ཆེན། ༼༡༣༦༤ - ༡༤༣༢༽ དགེ་ལྡན་པའི་རྗེ་ཡབ་སྲས་གསུམ་གྱི་ཡ་གྱལ། དགའ་ལྡན་ཁྲི་ཐོག་གཉིས་པ།

Namdrel Tharlam Salched Leu Dangpo

རྣམ་འགྲེལ་ཐར་ལམ་གསལ་བྱེད་ལེའུ་དང་པོ། ཆ ༼༠༨༤༽

སྒྲ་ཨང་། KADC3333265
མཁས་པ་གཞན། ༼འཆད་ཁྲིད་གཞན།༽ སྤྱིའི་ཨང་། ༣༩༣
འཁྲིད་མཁན། སེར་བྱེས་དགེ་བཤེས་མཁས་གྲུབ་ནོར་བཟང་། 
ཁྲིད་གཞུང་གི་མཚན་ཆ་ཚང་། རྗེ་བཙུན་བླ་མ་ཙོང་ཁ་པ་ཆེན་པོའི་ངོ་མཚར་རྨད་དུ་བྱུང་བའི་རྣམ་པར་ཐར་པ་དད་པའི་འཇུག་ངོགས་ཞེས་བྱ་བ་བཞུགས་སོ། །
མཛད་པ་པོ། རྗེ་ཙོང་ཁ་པ་བློ་བཟང་གྲགས་པ། ༼༡༣༥༧  -  ༡༤༡༩༽  མཛད་ཆེན་བཞི་སོགས་བསྟན་འགྲོའི་དོན་རྒྱ་ཆེར་མཛད། རི་བོ་དགེ་ལྡན་པའི་བསྟན་པའི་བདག་པོ། 
སྒྲིག་དུས། ༢༠༡༧ ལོའི་ཟླ་བརྒྱད་པ།

Je-tsongpa Namthar Dedpey Jug-ngok

རྗེ་ཙོང་ཁ་པའི་རྣམ་ཐར་དད་པའི་འཇུག་ངོགས། ༼༠༤༽

Professor Lorimer Moseley (PT, PhD) is Chair of Physiotherapy at the University of South Australia and a professor of Clinical Neurosciences. http://people.unisa.edu.au/lorimer.moseley
He combines Oxford rigour with a laconic and very popular Australian style of communication. In this podcast he addresses the questions: 
What’s new in our understanding of the spinal cord? 
What should we be telling patients? 
Is the ‘hands on, hands off’ debate a useful one? 
How do you feel the profession is performing right now? 
On the subject of what should we be telling patients, he argues we should train them to ask clinicians 3 questions. 
1.	How do I know my pain system is over-protective?
2.	What can I do to retrain my system to be less protective?
3.	Am I safe to move?
You can find his patient website ‘Tame the Beast’ here: https://www.tamethebeast.org/#home
And is previous BJSM podcast was on tendons. It has had >17K listens: http://ow.ly/5OGN30gkaD7.
And here is a link to the Pain Revolution website: https://www.painrevolution.org/

Am I safe to move? Professor Lorimer Moseley: New understanding of pain and focusing on the patient

Cristo Vive En Mi

Have we been thinking about Osgood Schlatter Disease (OSD) all wrong? To answer this question, Dr. Erin Macri interviewed Prof. Jens Lykkegaard Oleson and Dr. Sinead Holden from Aalborg University on a recent visit to Denmark. 
Prof. Olesen is a rheumatologist and sports medicine physician, currently located at the Center for Almen Medicine at Aalborg University. His research focuses on tendon and fascia tissue adaption to loading, and the use of ultrasound examination in tendon and fascia pathology. Dr. Holden is a Senior Researcher at the Center for General Practice in Aalborg, where she is co-founder and research co-ordinator for the OptiYouth Research Group focused on ‘optimising physical health in youth’. Her research aims to increase understanding of musculoskeletal injuries and pain in youth, to identify those at increased risk for developing chronic MSK problems.
In this episode, we delve into some recent evidence suggesting the OSD may not be the self-limiting condition we have typically believed it to be. In fact, OSD may be more akin to a tendonopathy in its presentation, which lends itself to exploring some novel treatment approaches that may change OSD management in clinical practice.

Related Articles and Links
OSD table: http://bjsm.bmj.com/pages/wp-content/uploads/sites/17/2019/06/OSD-table.pdf
Cairns G, Owen T, Kluzek S, Thurley N, Holden S, Rathleff MS, Dean BJ. Therapeutic interventions in children and adolescents with patellar tendon related pain: a systematic review. BMJ Open Sport Exerc Med. 2018 Aug 13;4(1):e000383. doi: 10.1136/bmjsem-2018-000383
https://bmjopensem.bmj.com/content/4/1/e000383
Holden S, Winiarski L, Krommes K, Thorborg K, Olesen JL, Hölmich P  & Rathleff MS. Prognosis of Osgood-Schlatter - poorer than anticipated? A prospective cohort study with 24-month follow-up. Presented at the Scandinavian Sports Medicine Conference 2019, Copenhagen, Denmark. 
Vad, CG; Rathleff, MS; Jensen, HP; Holden S. Osgood Schlatter is associated with significant impairments in knee function and quality of life 4 years after diagnosis: a retrospective study. Presented at the Scandinavian Sports Medicine Conference 2019, Copenhagen, Denmark. 
Lyng K, Rathleff MS, Dean B, Kluzek S, Holden S. Current Management Strategies in Osgood Schlatter: A quantitative study. Presented at the Scandinavian Sports Medicine Conference 2019, Copenhagen, Denmark. 
Kaya DO, Toprak U, Baltaci G, et al. Long-term functional and sonographic outcomes in Osgood-Schlatter disease. Knee Surg Sports Traumatol Arthrosc 2013;21(5):1131-9.
Krause BL, Williams JP, Catterall A. Natural history of Osgood-Schlatter disease. J Pediatr Orthop 1990;10(1):65-8.

Osgood Schlatter – not the self-limiting condition we once thought. Episode #384

This was composed after a night out, hence the name.  A nice jazz-inspired break with the bass towards the middle.  I feel it is a unique composition, complete with dual guitar harmonies.

Cthulu Pajamas

Runners are constantly trying to find the perfect shoe that will combine increased performance with decreased injury risk. In this podcast, Dr. Liam West poses the questions to Dr. Laurent Malisoux to explore whether the current body of research is able to guide the clinician as to which shoe type is perfect for which foot type. Dr. Malisoux is a key researcher at the Sports Medicine Research Laboratory at the Luxembourg Institute of Health. His area of research and expertise centres on running shoes and potential risk factors for injury.

Prescribing the perfect running shoe – myth busting podcast with Dr. Laurent Malisoux. Episode #422

Associate Editor Paul Blazey (T: @blazey85) talks with Professor Chad Cook from Duke University (North Carolina, USA). Chad is a Professor in the Orthopaedic Surgery Division of Physical Therapy, with an interest in the effective diagnosis, intervention, and outcomes assessment of conservative and surgical treatment of orthopedic-related conditions. 

Today we focus on Chad’s experience with orthopaedic testing, especially when applied to femoroacetabular impingement syndrome, and the ability to effectively assess this condition over telehealth.

Osgood Schlatter – not the self-limiting condition we once thought. Episode #384

BMJ talk medicine